Chronic Wound Infections: New Drug Therapy Hope
Summary: Scientists at the University of Oregon have identified a promising new therapy that combines low-dose chlorate with standard antibiotics to fight chronic wound infections. In laboratory tests against Pseudomonas aeruginosa, a common and stubborn wound pathogen, this combination improved antibacterial effectiveness by as much as 10,000-fold. The discovery could help restore the power of existing antibiotics, reduce treatment time, and minimize side effects for patients struggling with infected chronic wounds.
Key Highlights:
- New mechanism: Chlorate disrupts bacterial nitrate metabolism in low-oxygen wound environments, making pathogens more susceptible to antibiotics.
- Improved potency: Antibiotic efficacy increased dramatically, allowing for potential dose reductions.
- Clinical potential: The approach may shorten treatment duration, improve outcomes, and reduce toxicity in patients with chronic wound infections.
- Resistance relevance: This method could help combat antibiotic resistance by enhancing the effectiveness of existing drugs.
- Next steps: Further research and human clinical trials are needed to determine safety, dosage, and real-world effectiveness.
Read the full article on Time.News
Keywords:
Melanie Spero,
University of Oregon,
chlorate,
antibiotic synergy,
Pseudomonas aeruginosa,
chronic wound infection